DVLT is trading 10.9% up today at $0.46 after announcing its expansion into digital health through the launch of DelivMeds AI and a new partnership with Tyson Fury.
- The company is leveraging its data and AI platform to move into healthcare and consumer engagement via the new DelivMeds AI initiative.
- Shares are rebounding as investors shift focus toward these growth catalysts, moving past concerns regarding a recent $60 million dilutive stock offering.
- The rally is supported by a broadly positive market backdrop as traders react to the company's strategic business pivot.